Ambrose JB, Bennett HD; Lee HS, Josephson SA. «Cerebral vasculopathy after 4-bromo-2,5-dimethoxyphenethylamine ingestion». The Neurologist. 16: 199–202. PMID20445431. doi:10.1097/NRL.0b013e3181a3cb53
Caudevilla-Gálligo F, Riba J, Ventura M, González D, Farré M, Barbanoj MJ, Bouso JC. «4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects». Journal of Psychopharmacology. 26: 1026–35. PMID22234927. doi:10.1177/0269881111431752 !CS1 manut: Nomes múltiplos: lista de autores (link)
Caudevilla-Gálligo F, Riba J, Ventura M, González D, Farré M, Barbanoj MJ, Bouso JC. «4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects». Journal of Psychopharmacology. 26: 1026–35. PMID22234927. doi:10.1177/0269881111431752 !CS1 manut: Nomes múltiplos: lista de autores (link)
Bronson ME, Jiang W; DeRuiter J, Clark CR (1995). «A behavioral comparison of Nexus, cathinone, BDB, and MDA». Pharmacology Biochemistry and Behavior. 51: 473–5. PMID7667371. doi:10.1016/0091-3057(95)00013-M
Moya PR, Berg KA, Gutiérrez-Hernandez MA, Sáez-Briones P, Reyes-Parada M, Cassels BK, Clarke WP. «Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors». The Journal of Pharmacology and Experimental Therapeutics. 321: 1054–61. CiteSeerX10.1.1.690.3752. PMID17337633. doi:10.1124/jpet.106.117507 !CS1 manut: Nomes múltiplos: lista de autores (link)
«Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats». Psychopharmacology. 225: 75–93. PMID22842791. doi:10.1007/s00213-012-2797-7 !CS1 manut: número-autores (link)
Muehlenkamp F, Lucion A, Vogel WH. «Effects of selective serotonergic agonists on aggressive behavior in rats». Pharmacology Biochemistry and Behavior. 50: 671–4. PMID7617717. doi:10.1016/0091-3057(95)00351-7 !CS1 manut: Nomes múltiplos: lista de autores (link)
Ambrose JB, Bennett HD; Lee HS, Josephson SA. «Cerebral vasculopathy after 4-bromo-2,5-dimethoxyphenethylamine ingestion». The Neurologist. 16: 199–202. PMID20445431. doi:10.1097/NRL.0b013e3181a3cb53
Caudevilla-Gálligo F, Riba J, Ventura M, González D, Farré M, Barbanoj MJ, Bouso JC. «4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects». Journal of Psychopharmacology. 26: 1026–35. PMID22234927. doi:10.1177/0269881111431752 !CS1 manut: Nomes múltiplos: lista de autores (link)
de Boer D, Gijzels MJ; Bosman IJ, Maes RA (1999). «More data about the new psychoactive drug 2C-B». Journal of Analytical Toxicology. 23: 227–8. PMID10369336
Caudevilla-Gálligo F, Riba J, Ventura M, González D, Farré M, Barbanoj MJ, Bouso JC. «4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects». Journal of Psychopharmacology. 26: 1026–35. PMID22234927. doi:10.1177/0269881111431752 !CS1 manut: Nomes múltiplos: lista de autores (link)
Bronson ME, Jiang W; DeRuiter J, Clark CR (1995). «A behavioral comparison of Nexus, cathinone, BDB, and MDA». Pharmacology Biochemistry and Behavior. 51: 473–5. PMID7667371. doi:10.1016/0091-3057(95)00013-M
Moya PR, Berg KA, Gutiérrez-Hernandez MA, Sáez-Briones P, Reyes-Parada M, Cassels BK, Clarke WP. «Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors». The Journal of Pharmacology and Experimental Therapeutics. 321: 1054–61. CiteSeerX10.1.1.690.3752. PMID17337633. doi:10.1124/jpet.106.117507 !CS1 manut: Nomes múltiplos: lista de autores (link)
«Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats». Psychopharmacology. 225: 75–93. PMID22842791. doi:10.1007/s00213-012-2797-7 !CS1 manut: número-autores (link)
Muehlenkamp F, Lucion A, Vogel WH. «Effects of selective serotonergic agonists on aggressive behavior in rats». Pharmacology Biochemistry and Behavior. 50: 671–4. PMID7617717. doi:10.1016/0091-3057(95)00351-7 !CS1 manut: Nomes múltiplos: lista de autores (link)
Moya PR, Berg KA, Gutiérrez-Hernandez MA, Sáez-Briones P, Reyes-Parada M, Cassels BK, Clarke WP. «Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors». The Journal of Pharmacology and Experimental Therapeutics. 321: 1054–61. CiteSeerX10.1.1.690.3752. PMID17337633. doi:10.1124/jpet.106.117507 !CS1 manut: Nomes múltiplos: lista de autores (link)